$COAG

$38.40 +$2.38 (6.61%) Close

$COAG Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 46.7M shares outstanding

Who owns COAG?

By type of holder

Institutions 77.6% Insiders 22.4% Everyone else 0.0%

Concentration Top 10 holders own 101.2%

Ra Capital Management, L.P. 16.7% · Ai Den-Mab LLC 10.4%

Institutional ownership

77.6%

+77.6 pts vs last qtr

Institutional holders

+56 vs last qtr

Net shares bought

+36.3M

by institutions in Q2 2026

New / sold out

56 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Ra Capital Management, L.P. NEW +7.8M
Novo Holdings A/s NEW +4.2M

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Hemab Therapeutics Holdings Inc in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for Hemab Therapeutics Holdings Inc.

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years0% Under 1 year100%

Quarterly turnover

—

of institutional shares changed hands

Top 10 managers, median time held

0 quarters

Super Investors

Investment managers reporting COAG on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
RC Ra Capital Management, L.P.	7.8M	16.72%	NEW	Q2 '26	2.5%
Shares held by quarter Peak holding7.8M (Q2'26) Change over 8 quarters+7.8M Share of the company16.720% Ra Capital Management, L.P.'s full portfolio →
NH Novo Holdings A/s	4.2M	8.95%	NEW	Q2 '26	8.9%
Shares held by quarter Peak holding4.2M (Q2'26) Change over 8 quarters+4.2M Share of the company8.950% Novo Holdings A/s's full portfolio →

Ra Capital Management, L.P.

7.8M

% of company

16.72%

Change vs last qtr

NEW

Held since

Q2 '26

Novo Holdings A/s

4.2M

% of company

8.95%

Change vs last qtr

NEW

Held since

Q2 '26

23 more super investors behind a free account

See every manager holding Hemab Therapeutics Holdings Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting COAG on Form N-PORT; together they hold 20.6% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
SW SMALLCAP World Fund Inc SMALLCAP World Fund Inc	$129M	3.5M	7.51%	0.14%	June 30, 2026
FG Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust	$24M	523.9K	1.12%	0.02%	August 31, 2026

SMALLCAP World Fund Inc

Position value

$129M

% of company

7.51%

% of the fund

0.14%

As of

June 30, 2026

Fidelity Growth Company Fund

Fidelity Mt. Vernon Street Trust

Position value

$24M

% of company

1.12%

% of the fund

0.02%

As of

August 31, 2026

23 more funds behind a free account

See every fund holding Hemab Therapeutics Holdings Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
AD Ai Den-Mab LLC 5%+ holder 13D · 10.4%	4.9M	10.44%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company10.440% Disclosed stake13D · 10.4% View the 13D/G filing →
AI Access Industries Holdings LLC 5%+ holder 13D · 10.4%	4.9M	10.44%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company10.440% Disclosed stake13D · 10.4% View the 13D/G filing →

Ai Den-Mab LLC

5%+ holder13D · 10.4%

4.9M

% of company

10.44%

Change vs last qtr

—

Held since

—

Access Industries Holdings LLC

5%+ holder13D · 10.4%

4.9M

% of company

10.44%

Change vs last qtr

—

Held since

—

5 more holders behind a free account

See every insider and 5%+ holder of Hemab Therapeutics Holdings Inc.

Comments